期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
PD患者全身免疫炎症指数和免疫球蛋白水平与运动并发症的关联性分析
1
作者 冯婷婷 夏欢 +2 位作者 王子豪 张明洋 杨新玲 《新疆医科大学学报》 CAS 2024年第2期203-208,共6页
目的研究帕金森(Parkinson's disease,PD)患者全身免疫炎症指数和免疫球蛋白水平与运动并发症的关联性。方法以2022年1月-2023年6月新疆医科大学第二附属医院神经内科确诊PD住院患者218例为研究对象,根据患者临床症状是否发生症状... 目的研究帕金森(Parkinson's disease,PD)患者全身免疫炎症指数和免疫球蛋白水平与运动并发症的关联性。方法以2022年1月-2023年6月新疆医科大学第二附属医院神经内科确诊PD住院患者218例为研究对象,根据患者临床症状是否发生症状波动和异动症分为有运动并发症组和无运动并发症组。收集两组患者一般资料,采用SYSMEX XN-3000全自动分析仪检测两组血常规并计算中性粒细胞计数/淋巴细胞比值(Neutrophil-lymphocyte ratio,NLR)、全身免疫炎症指数(Systemic immune-inflammation index,SII),采用美国贝克曼尔特特种蛋白分析仪检测两组A-白蛋白及α1、α2、β、γ免疫球蛋白。结果与无运动并发症组比较,有运动并发症组NLR、SII和γ-球蛋白升高,A-白蛋白降低,差异具有统计学意义(P<0.05)。Logistic回归分析结果显示SII、A-白蛋白、γ-球蛋白、H-Y分期是PD运动并发症的危险因素(P<0.05)。ROC工作曲线分析结果显示SII、A-白蛋白、γ-球蛋白和H-Y分期对预测PD运动并发症的AUC值分别为0.752、0.643、0.704、0.746,95%CI分别为0.683~0.822、0.549~0.737、0.619~0.788、0.670~0.823。联合检测的AUC值为0.858,95%CI为0.796~0.920。结论高水平的SII及γ-球蛋白、H-Y分期和较低的A-白蛋白可增加PD发生运动并发症的风险。 展开更多
关键词 帕金森 中性粒细胞/淋巴细胞比值 全身免疫炎症指数 γ免疫球蛋白 运动并发症
下载PDF
A Study of the Relationship_Between Levels of SIgA and IFN-γ in the Female Genital Tract and the Clinical Course of NGU 被引量:4
2
作者 李燕 刘全忠 《Chinese Journal of Sexually Transmitted Infections》 2005年第1期37-39,共3页
Objective: To study the relationship of local immunity in the female genital tract with the clinical course of Nongonococcal Urethritis (NGU). Methods: We collected cervical secretions from patients and examined l... Objective: To study the relationship of local immunity in the female genital tract with the clinical course of Nongonococcal Urethritis (NGU). Methods: We collected cervical secretions from patients and examined levels of SIgA and IFN- γ. Results: Levels of SIgA and IFN- γ in the infected group were lower than those in the uninfected group, P1〈0.05 and P2〈0.05. The level of SIgA and IFN- γ in C.t,UU and C.t+UU infected groups were not significantly different. Comparing the negative-changed group with thenonnegative-changed group, the level of SIgA and IFN-γ was 39.22±20.04mg/L and 103.19±29.94pg/ml, 26.00±10.56mg/I and 88.21±15.10pg/ml, P1〉0.05 and P2〉0.05. Conclusion: SIgA and IFN-γ secreted by genital tractmucosa may help prevent and resist local NGU infection.However, the effect is limited, and is insufficient to eliminate infection completely and prevent reinfection. 展开更多
关键词 NGU C.t UU SIGA IFN- γ Local immunity
下载PDF
Clinical efficacy of acupuncture in treatment ofchronic urticaria and its effects on the content of IgE and the imbalance of Th1/Th2 cell function 被引量:3
3
作者 Zhang Xin Ji Jun Hong Jue 《Journal of Acupuncture and Tuina Science》 CSCD 2020年第2期149-156,共8页
Objective:To observe the clinical efficacy of acupuncture in treatment of chronic urticaria and the change in the content of serum immunoglobulin E(IgE),and to discuss the effect of acupuncture on the imbalance of T h... Objective:To observe the clinical efficacy of acupuncture in treatment of chronic urticaria and the change in the content of serum immunoglobulin E(IgE),and to discuss the effect of acupuncture on the imbalance of T helper(Th)1/Th2 cell function via observing the changes in the contents of interferon-y(IFN-y)and interleukin-4(IL-4).Methods:Ninety patients meeting the inclusion criteria of chronic urticaria were randomized into an acupuncture-medication group,an acupuncture group and a Western medication group by the random number table method.The acupuncture-medication group was intervened by acupuncture,cupping,collateral-pricking bloodletting and oral administration of cetirizine hydrochloride tablets;the acupuncture group was treated with acupuncture,cupping and collateral-pricking bloodletting;the Western medication group only received oral administration of cetirizine hydrochloride tablets.Before treatment and after 6-week treatment,the changes in the symptom scores and the contents of serum IgE,IFN-γ and IL-4 in the three groups were observed.Results:There were no significant differences in the total effective rate among the three groups(all P>0.05),but the cured and markedly effective rate was significantly higher in the acupuncture-medication group than that in the Western medication group(P<0.05).After treatment,the total symptom score decreased in the three groups(P<0.05),and the improvement of total symptom score in the acupuncture-medication group was more significant than that in the Western medication group(P<0.05).The component symptom scores all decreased after treatment in the three groups(all P<0.05);the improvements of the scores of itch intensity,and skin lesion size and number were more significant in the acupuncture-medication group than in the Western medication group(all P<0.05);the improvement of the skin lesion size score was more significant in the acupuncture group than in the Western medication group(P<0.01).The contents of IgE and IL-4 dropped(all P<0.05)and the content of IFN-y increased(P<0.05)after treatment in the three groups;the post-treatment changes in the serum contents of IgE and IFN-y were more significant in the acupuncture-medication group than in the Western medication group(both P<0.05).The incidence rate of adverse reactions was significantly lower in the acupuncture-medication group and acupuncture group than in the Western medication group(both P<0.05),and the relapse rate was significantly lower in the acupuncture-medication group than in the Western medication group(P<0.05).Conclusion:Combined acupuncture and medication can enhance the cured and markedly effective rate in treating chronic urticaria.Acupuncture is equivalent to cetirizine hydrochloride tablets comparing the clinical efficacy in treatment of chronic urticaria.Acupuncture plus medication and acupuncture alone both can effectively mitigate the clinical symptoms,with low incidence of adverse reactions.The relapse rate is low when using acupuncture together with medication.Acupuncture plus medication can work better in regulating the contents of IgE and IFN-y and improving the imbalance of Th1/Th2 cell function. 展开更多
关键词 Acupuncture Therapy Cupping Therapy Blood-letting Puncturing and Cupping Therapy Acupuncture Medication Combined URTICARIA Immunoglobulin E INTERFERON-GAMMA lnterleukin-4
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部